Filtros de búsqueda

Lista de obras de Martin Rowe

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

artículo científico publicado en 2010

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

artículo científico publicado en 2009

Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression

artículo científico publicado en 2004

Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin's Lymphoma

artículo científico publicado en 2012

Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells

artículo científico publicado en 2006

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

artículo científico publicado en 2012

Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.

artículo científico publicado en 2009

CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.

artículo científico publicado en 2001

Cell transformation induced by Epstein–Barr virus—living dangerously ⬇️

artículo científico publicado el 1 de diciembre de 2001

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription

artículo científico publicado en 2001

Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus

artículo científico publicado en 1988

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

artículo científico publicado en 1995

Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle

artículo científico publicado en 2014

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions

artículo científico publicado en 2014

Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells

artículo científico publicado en 1990

Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition

artículo científico publicado en 2009

Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient

artículo científico publicado en 1993

Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines

artículo científico publicado en 1996

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.

artículo científico publicado en 1982

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations

artículo científico publicado en 2011

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

artículo científico publicado en 1990

Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma

artículo científico publicado en 1985

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

artículo científico publicado en 2011

Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes

artículo científico publicado en 1997

Effect of the EBNA-2 gene on the surface antigen phenotype of transfected EBV-negative B-lymphoma lines

artículo científico publicado en 1990

Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma

artículo científico

Epstein Barr virus entry; kissing and conjugation

artículo científico publicado en 2014

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

artículo científico publicado en 1991

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

artículo científico publicado en 2001

Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5

artículo científico publicado en 2003

Epstein-Barr virus and Burkitt lymphoma.

artículo científico publicado en 2014

Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.

scientific article published on 25 October 2008

Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders

artículo científico publicado en 1998

Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion.

artículo científico publicado en 2005

Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes

artículo científico publicado en 2007

Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.

artículo científico publicado en 2011

Epstein-Barr virus latent genes in tumour cells of Hodgkin's disease

artículo científico publicado en 1991

Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells.

artículo científico publicado en 2011

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

artículo científico publicado en 1997

Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions

artículo científico publicado en 1998

Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.

artículo científico publicado en 2002

Epstein-Barr virus regulates STAT1 through latent membrane protein 1.

artículo científico publicado en 2003

Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A

artículo científico publicado en 2006

Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma

artículo científico publicado en 1986

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.

artículo científico publicado en 2010

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

artículo científico publicado en 1993

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

artículo científico publicado en 1997

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

artículo científico publicado en 1989

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance

artículo científico publicado en 1985

Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen

artículo científico publicado en 1982

Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes

artículo científico publicado en 1987

Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

artículo científico

Epstein-barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome

artículo científico publicado en 2003

Establishment of an EBV-positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules

artículo científico publicado en 1990

Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor

artículo científico publicado en 1986

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

artículo científico publicado en 1991

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

artículo científico publicado en 1991

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

artículo científico publicado en 1988

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification

artículo científico publicado en 2009

HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection

artículo científico publicado en 1994

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

artículo científico publicado en 1993

Herpesviruses Placating the Unwilling Host: Manipulation of the MHC Class II Antigen Presentation Pathway ⬇️

artículo científico publicado el 22 de agosto de 2012

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses

artículo científico publicado en 1990

Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas

artículo científico publicado en 2012

Identification of Epstein-Barr Virus Replication Proteins in Burkitt's Lymphoma Cells

artículo científico publicado en 2015

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies ⬇️

artículo científico publicado el 1 de julio de 1992

Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity

artículo científico publicado en 2010

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

artículo científico

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

artículo científico publicado en 1991

Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation

artículo científico publicado en 2013

Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma

artículo científico publicado en 1998

Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus

artículo científico publicado en 1988

Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis

artículo científico publicado en 2013

Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

artículo científico publicado en 2003

Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.

artículo científico publicado en 2003

Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes

scientific article published on 01 September 1986

Lymphoblastoid cells transfected with c-myc: downregulation of EBV-lytic antigens and impaired response of autologous CD4+ T cells in vitro

artículo científico publicado en 1996

Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.

artículo científico publicado en 1994

MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways

artículo científico publicado en 1993

Mechanism of action of a novel latent membrane protein-1 dominant negative

artículo científico publicado en 2001

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

artículo científico publicado en 2015

Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. ⬇️

artículo científico publicado en 2009

Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity

artículo científico publicado en 1982

Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells

artículo científico publicado en 1987

NF-kappaB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus

artículo científico publicado en 2003

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

artículo científico publicado en 2004

Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells

artículo científico publicado en 2002

Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody

artículo científico publicado en 1994

Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation ⬇️

artículo científico publicado el 10 de noviembre de 2010

Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line

artículo científico publicado en 1981

Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines

artículo científico publicado en 1994

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

artículo científico publicado en 1995

Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition

artículo científico publicado en 1992

Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site

scientific article published on July 1991

STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells

artículo científico publicado en 2009

Selective reactivation of Epstein-Barr virus-specific cytotoxic T cells by stimulation in vitro with allogeneic virus-transformed HLA-homozygous typing cells

artículo científico publicado en 1983

Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle

artículo científico publicado en 2009

Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response

artículo científico publicado en 1982

Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation

artículo científico publicado en 1982

Summary of roundtable discussion meeting: non-human primates to assess risk for EBV-related lymphomas in humans

scientific article published on 03 December 2011

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

artículo científico publicado en 2013

Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression

artículo científico publicado en 2005

T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.

artículo científico publicado en 1984

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

artículo científico publicado en 2014

The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function

artículo científico publicado en 2007

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation

artículo científico publicado en 2009

The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers

artículo científico publicado en 1991

The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways

artículo científico publicado en 2010

The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy

artículo científico publicado en 1989

The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma

artículo científico publicado en 2011

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

scientific article published on 01 May 1995

The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line

artículo científico publicado en 2000

The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis

artículo científico publicado en 1995

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

artículo científico publicado en 2006

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage

artículo científico publicado en 1992

Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines

scientific journal article

Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda